ALSN vs LEVI

Allison Transmission (ALSN) exhibits strong fundamental health with a Piotroski F-Score of 8/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The company shows exceptional profitability, including a 40.38% ROE and 27.33% operating margin, significantly outperforming sector averages. However, elevated valuation metrics, a bearish technical trend, and recent insider selling offset these strengths. While growth and cash flow fundamentals are strong, the stock trades above its Graham Number of $33.58 but below the growth-based intrinsic value of $237.18, suggesting mixed signals on valuation.

LEVI presents a compelling growth-at-a-reasonable-price (GARP) opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.30) that sits comfortably below its growth-based intrinsic value of $40.12. While the Graham Number suggests a lower defensive floor of $13.25, the company's exceptional ROE of 25.41% and strong earnings growth (32.6% YoY) justify a premium. Despite bearish insider sentiment and a weak technical trend, the fundamental trajectory is supported by consistent earnings beats and a P/E ratio significantly lower than the sector average.